Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...

Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

The Senate Homeland Security Committee holds a hearing on federal health agencies failing to warn the public about the potential side effects of the COVID-19 vaccines. At a Permanent Subcommittee on ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The wide moat strategy involves investing in companies that not only lead their industries but are also strategically ...

The FDA has ordered Pfizer and Moderna to amend the warning labels on their COVID-19 vaccines with risk of myocarditis and pericarditis.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Pfizer’s news about the effectiveness of its COVID-19 vaccine came nearly a week after Election Day, but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics. In an ...

Pfizer, one of the front-runners in the quest for a COVID-19 vaccine, said its candidate vaccine looks safe, and the company expects to have data next month on how well it protects people against ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...